Microneedling for hair loss

Key takeaways

• Microneedling is an add-on to minoxidil, not a treatment by itself. Meta-analyses of 10 to 13 randomized trials (466 to 696 people) found larger hair-count gains with microneedling plus topical minoxidil than with minoxidil alone (Abdi 2023; Pei 2024; Ahmed 2025).
• The only randomized trial of microneedling alone (30 men, monthly sessions) found no gain in hair density (Kakizaki 2023).
• The largest and most careful trial was negative. In 245 women with female pattern hair loss on 2% minoxidil, adding microneedling every 2 or 4 weeks for 24 weeks made no difference to the result (Liu 2026). It was open-label and used shallow needles, so it does not settle the question for men on 5% minoxidil.
• The best-known positive trial is weaker than its headline. In 100 men over 12 weeks, weekly 1.5 mm rolling plus 5% minoxidil gained 91.4 hairs against 22.2 for minoxidil alone (Dhurat 2013). Patients were not blinded and no later trial has matched that effect size.
• Deeper needles are not better. Pooled results showed no difference between needles of 1 mm or less and longer ones (Ahmed 2025), and in one trial 0.6 mm beat minoxidil alone while 1.2 mm did not clearly do so (Faghihi 2021).
• It probably increases how much of an applied product is absorbed. Diastolic blood pressure fell after 0.5% minoxidil was microinfused into the scalp (Basilio 2025), and cosmetic serums applied after needling have caused foreign-body granulomas (Soltani-Arabshahi 2014).
• Done cleanly it is usually safe, but home use has real failure modes, including a reported skull-level abscess after home dermarolling (Jain 2026).

What it is

A roller, stamp or motorized pen pushes many fine needles (0.25 to 2.5 mm in trials) into the scalp to make controlled micro-wounds. Variants include radiofrequency microneedling and microinfusion, where a tattoo-style machine drives a drug into the skin (Basilio 2025). Microinfusion overlaps with mesotherapy.

How it might work

These ideas are mostly unproven in people.

• Wound-healing signals. Injury releases growth factors and may activate Wnt/beta-catenin signalling. Biopsies in one trial showed raised pathway markers after microneedling plus minoxidil (Bao 2022).
• Better drug delivery. The needle channels cross the skin barrier, and the blood-pressure changes after microinfusion show minoxidil reaches the bloodstream (Basilio 2025).
• Microneedling does not carry large proteins deeper. A histology study found no enhanced delivery of growth factors, which undercuts the common clinic pairing of microneedling with topical PRP or exosomes (Dhurat 2019).

What the studies show

• Dhurat 2013, 100 men, 12 weeks: weekly 1.5 mm rolling plus 5% minoxidil gave +91.4 hairs against +22.2 for minoxidil alone, and 82% vs 4.5% rated themselves more than 50% better (Dhurat 2013).
• Kumar 2018, 68 men: +12.52 vs +1.89 hairs per square inch, which the authors themselves called not cosmetically significant (Kumar 2018).
• Bao 2020, 60 men, 24 weeks: density rose 18.8 per cm2 with minoxidil, 23.4 with microneedling, and 38.3 with both (Bao 2020).
• Network meta-analysis, 27 trials and 1,110 people: minoxidil 5% plus microneedling ranked first, about 13 hairs per cm2 more than minoxidil alone (Gupta 2023).
• Meta-analysis, 12 trials: hair-count effect size 1.32 but with very high heterogeneity (I2 of 88%), a sign that the trials disagree and may be biased (Ahmed 2025).
• Liu 2026, 245 women, 24 weeks: no difference between 2% minoxidil alone and with microneedling at 0.5 to 0.55 mm (Liu 2026).
• A 2025 Canadian expert consensus listed microneedling among 7 recommended interventions for pattern hair loss (Landells 2025).

How to read this: nearly all positive trials are small, single-centre, unblinded for patients and short (12 to 24 weeks), and their minoxidil-only groups often did worse than minoxidil does in its own large trials. That pattern fits bias in open-label add-on trials. The meta-analyses were published before the negative 2026 trial, so an updated pooled result would probably shrink the benefit.

How it's used in studies

Trials used needles of 0.6 to 1.5 mm, sessions from weekly to monthly, for 12 to 24 weeks, together with topical minoxidil. Dhurat 2013 needled weekly to mild redness, skipped minoxidil on the session day and restarted it 24 hours later (Dhurat 2013). Fortnightly and monthly sessions performed the same in the 2026 trial. Daily use has not been studied.

Side effects and safety

• Common effects are temporary redness, pain and pinpoint bleeding. Active infection and metal allergy are listed risk factors, and darker skin types are more prone to dark marks after the skin heals (Chu 2021).
• Serious events are rare and mostly case reports: an abscess under the scalp membrane with skull-bone infection after home dermarolling (Jain 2026), and a basal cell carcinoma at a hairline spot needled daily for 3 months, where causation is unproven (Aydemir 2026).
• Only apply products made for use on broken skin after needling. Higher minoxidil absorption matters for anyone with low blood pressure or a heart condition.
• Swelling, spreading pain, pus or fever after needling need prompt medical care.

Bottom line

Microneedling may add a little to minoxidil, but the evidence is mixed and the biggest trial found nothing extra. It should never replace minoxidil or finasteride. If you try it, use a clean single-use device, avoid needling over irritated or infected skin, and skip daily needling. Discuss with a doctor.